ArTS Archivio della ricerca di Trieste

PORCARI, ALDOSTEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.251
NA - Nord America 4.930
EU - Europa 4.593
SA - Sud America 733
AF - Africa 135
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.762
SG - Singapore 1.990
IT - Italia 1.936
CN - Cina 1.242
BR - Brasile 574
HK - Hong Kong 533
VN - Vietnam 511
DE - Germania 438
KR - Corea 387
FR - Francia 321
FI - Finlandia 266
NL - Olanda 255
GB - Regno Unito 254
SE - Svezia 244
PL - Polonia 177
RU - Federazione Russa 177
IN - India 137
CH - Svizzera 94
JP - Giappone 78
CA - Canada 74
IE - Irlanda 71
AT - Austria 68
BG - Bulgaria 67
AR - Argentina 60
MX - Messico 54
TR - Turchia 54
MA - Marocco 45
ES - Italia 40
BD - Bangladesh 38
ID - Indonesia 34
IQ - Iraq 32
UA - Ucraina 30
SA - Arabia Saudita 26
ZA - Sudafrica 25
CO - Colombia 24
CZ - Repubblica Ceca 24
BE - Belgio 23
PK - Pakistan 18
EC - Ecuador 17
VE - Venezuela 17
CL - Cile 16
IR - Iran 16
EG - Egitto 15
AU - Australia 14
RO - Romania 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
GR - Grecia 11
IL - Israele 11
JO - Giordania 11
PE - Perù 11
LT - Lituania 10
TH - Thailandia 10
UZ - Uzbekistan 10
DZ - Algeria 9
MY - Malesia 9
NO - Norvegia 9
OM - Oman 9
PH - Filippine 9
KE - Kenya 8
PA - Panama 8
BY - Bielorussia 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
PT - Portogallo 7
SI - Slovenia 7
SK - Slovacchia (Repubblica Slovacca) 7
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
AO - Angola 4
AZ - Azerbaigian 4
BO - Bolivia 4
HR - Croazia 4
NP - Nepal 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
CU - Cuba 3
DK - Danimarca 3
GA - Gabon 3
JM - Giamaica 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MM - Myanmar 3
MU - Mauritius 3
SM - San Marino 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
Totale 15.616
Salva come PNG Salva come JPEG
Città #
Singapore 1.108
Ashburn 730
San Jose 540
Hong Kong 515
Hefei 496
Seoul 382
Chandler 363
Trieste 267
Beijing 218
Helsinki 205
Milan 198
Boardman 197
Council Bluffs 188
Ho Chi Minh City 164
Munich 163
Dallas 149
Chicago 144
Fairfield 143
Los Angeles 140
Hanoi 115
Rome 111
Lauterbourg 110
Zgierz 102
London 100
Santa Clara 100
Columbus 91
New York 83
Seattle 82
Moscow 73
Frankfurt am Main 72
Houston 72
Bern 71
Dublin 70
Wilmington 69
Woodbridge 67
The Dalles 65
Sofia 63
São Paulo 61
Princeton 56
Cambridge 53
Naples 53
Warsaw 52
Buffalo 50
Nuremberg 44
Vienna 43
Tokyo 38
Lappeenranta 36
Orem 34
Turin 34
Amsterdam 32
Redondo Beach 32
Casablanca 29
Da Nang 29
Shanghai 29
Washington 29
Ann Arbor 28
Montreal 28
Chennai 26
Florence 26
Paris 26
Udine 25
Brooklyn 24
Denver 24
Jacksonville 23
Phoenix 22
Atlanta 21
Düsseldorf 21
Venice 21
Mumbai 20
Turku 20
Verona 20
Boydton 19
Padova 19
Toronto 19
Belo Horizonte 18
Palermo 18
Stockholm 18
Venezia 18
Bari 17
Bologna 17
Parma 17
Izmir 16
Brussels 15
Haiphong 15
Karlsruhe 15
Roubaix 15
Genoa 14
Manchester 14
Barnet 13
Biên Hòa 13
Brasília 13
Bremen 13
Guangzhou 13
Istanbul 13
Madrid 13
Poplar 13
Tianjin 13
Wuhan 13
Boston 12
Brno 12
Totale 9.373
Salva come PNG Salva come JPEG
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 519
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 358
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 286
Cardiac amyloidosis: a changing epidemiology with open challenges 278
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 263
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 252
Clinical validation of a coronary surgery technique that minimizes aortic manipulation 245
Cardiovascular aging: the unveiled enigma from bench to bedside 240
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib 236
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 218
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 206
The fate of patients having deep sternal infection after bilateral internal thoracic artery grafting in the negative pressure wound therapy era 202
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 200
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 191
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy 190
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy 189
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 188
Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia 179
Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis 176
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 170
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 169
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 166
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 165
The (ultra) sound of a burning heart: A matter of speckles 165
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones 160
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 159
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 158
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 158
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 157
Myocarditis: Which Role for Genetics? 157
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 156
Validation and Performance Comparison of Two Scoring Systems Created Specifically to Predict the Risk of Deep Sternal Wound Infection after Bilateral Internal Thoracic Artery Grafting 155
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 153
Grey zones in the supportive treatments of cardiac amyloidosis 153
Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy 153
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 153
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors 145
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death 143
Cardiac amyloidosis: do not forget to look for it 140
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization 140
Clinical Use of Biomarkers in Cardiac Amyloidosis 138
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery 138
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience 137
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination 136
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 134
Re-Definition of the Epidemiology of Cardiac Amyloidosis 133
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 132
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 129
The Arrhythmic Phenotype in Cardiomyopathy 128
Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure 120
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 119
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca 116
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 115
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance 114
Che cos’è l’Amiloidosi? 110
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 109
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 109
Editorial for the article: Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy 109
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy 109
Dieci possibili linee future di ricerca e innovazione nell’amiloidosi cardiaca 109
Restrictive cardiomyopathy: definition and diagnosis 107
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 107
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy 107
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 105
Cardiac Amyloidosis 104
Transthyretin cardiac amyloidosis 104
One-Year Risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis 103
Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017 103
Lung damage in SARS-CoV-2 patients: An autopsy study in the era of vaccination 102
Precision medicine in heart failure no longer a visual theory but a realistic opportunity 100
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis 98
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years 97
Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis 96
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis 96
Atrial electro-functional predictors of incident atrial fibrillation in cardiac amyloidosis 96
Update 2022 dell’Expert Opinion della Società Italiana di Cardiologia su miocarditi, pericarditi e vaccini contro il COVID-19 95
Cardiac amyloidosis: when to suspect and how to confirm 94
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide 94
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 94
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 93
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 93
Myocardial perfusion in cardiac amyloidosis 91
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 90
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery 90
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 89
Patologie acute del pericardio 88
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis 87
Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis 87
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis 87
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis 85
Comparison of 99mTc-DPD Scintigraphy, CMR Imaging, and Echocardiography in Patients With V30M-Associated Hereditary Transthyretin Amyloidosis 84
Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine 82
Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici 79
Management of hypertrophic cardiomyopathy 79
Filling the gap in epidemiology, management and clinical course of COVID-19 vaccination-related pericarditis 77
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 76
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 74
The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium–glucose cotransporter 2 inhibitors? 73
Expert consensus document on artificial intelligence of the Italian Society of Cardiology 72
Totale 14.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 75 22 38
2021/2022538 28 35 47 28 31 42 34 31 67 37 63 95
2022/20231.357 72 161 152 192 106 188 35 122 159 35 90 45
2023/20241.844 164 92 97 146 138 145 265 235 44 98 213 207
2024/20253.867 136 178 381 303 330 273 286 244 403 555 329 449
2025/20267.661 699 619 712 759 620 754 1.137 375 1.060 926 0 0
Totale 16.081